Possible mechanisms for anti-cancer activity of metformin include inhibition of the unfolded protein response, induction of apoptosis, reductions in the levels of circulating insulin, and activation of specific metabolic pathways, such as liver kinase B1 and adenosine monophosphate-activated protein kinase (AMPK) [11, 12]. The gene discussed is INS; the disease is cancer.